Medical technology continues to advance all the time, with life-saving procedures and medicines that were previously unheard of. Now, Global Data believe that 3D printing could be as disruptive to healthcare as the internet has been to retail.
The company initiated a study for its Disruptor Tech database, and the results revealed that 3D printing could revolutionise the supply chain by limiting the gaps between sourcing, production, and distribution. 3D printing has the ability to create ‘clinical trial ready’ devices without the need for expensive tools, computer-aided manufacturing, and computer numerically controlled manufacturing. As a result of this, price is lowered and waiting times are also reduced.